Complement receptor type 1 (CR1, CD35) is a receptor for C1q

被引:197
作者
Klickstein, LB
Barbashov, SF
Liu, T
Jack, RM
NicholsonWeller, A
机构
[1] BRIGHAM & WOMENS HOSP, DEPT MED, DIV RHEUMATOL IMMUNOL, BOSTON, MA 02215 USA
[2] BETH ISRAEL DEACONESS MED CTR, DIV INFECT DIS, HARVARD THORNDIKE LAB, CHARLES A DANA RES INST, BOSTON, MA 02215 USA
[3] LA JOLLA PHARMACEUT, SAN DIEGO, CA 92121 USA
关键词
D O I
10.1016/S1074-7613(00)80356-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Molecular definition of the cellular receptor for the collagen domain of C1q has been elusive. We now report that C1q binds specifically to human CR1 (CD35), the leukocyte C3b/C4b receptor, and the receptor on erythrocytes for opsonized immune complexes. Biotinylated or radioiodinated C1q (*C1q) bound specifically to transfected K562 cells expressing cell surface CR1 and to immobilized recombinant soluble CR1 (rsCR1). *C1q binding to rsCR1 was completely inhibited by unlabeled C1q and the collagen domain of C1q and was partially inhibited by C3b dimers. Kinetic analysis in physiologic saline of the interaction of unlabeled C1q with immobilized rsCR1 using surface plasmon resonance yielded an apparent equilibrium dissociation constant (K-eq2) of 3.9 nM. Thus, CR1 is a cellular C1q receptor that recognizes al three complement opsonins, namely, C1q, C3b, and C4b.
引用
收藏
页码:345 / 355
页数:11
相关论文
共 73 条
  • [1] ARNAOUT MA, 1981, J IMMUNOL, V127, P1348
  • [2] COMPLEMENT ACTIVATION AND COMPLEMENT RECEPTORS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ATKINSON, JP
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1986, 9 (2-3): : 179 - 194
  • [3] ANTIBODY-INDEPENDENT CLASSICAL PATHWAY-MEDIATED OPSONOPHAGOCYTOSIS OF TYPE-IA, GROUP-B STREPTOCOCCUS
    BAKER, CJ
    EDWARDS, MS
    WEBB, BJ
    KASPER, DL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (02) : 394 - 404
  • [4] Bleackley R C, 1995, Curr Top Microbiol Immunol, V198, P145
  • [5] BOWNESS P, 1994, Q J MED, V87, P455
  • [6] BROWN EJ, 1989, J BIOL CHEM, V264, P6196
  • [7] CHANGELIAN PS, 1985, J IMMUNOL, V134, P1851
  • [8] CHEN A, 1994, J IMMUNOL, V153, P1430
  • [9] CHEVALIER J, 1989, J IMMUNOL, V142, P2031
  • [10] COMPLEMENT DEFICIENCIES
    COLTEN, HR
    ROSEN, FS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1992, 10 : 809 - 834